GE HealthCare Technologies Inc. $GEHC Shares Purchased by Whittier Trust Co.

Whittier Trust Co. lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.0% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 132,597 shares of the company’s stock after purchasing an additional 2,550 shares during the quarter. Whittier Trust Co.’s holdings in GE HealthCare Technologies were worth $9,820,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. Hotchkis & Wiley Capital Management LLC boosted its position in shares of GE HealthCare Technologies by 3.2% in the 1st quarter. Hotchkis & Wiley Capital Management LLC now owns 5,751,773 shares of the company’s stock valued at $464,226,000 after purchasing an additional 176,572 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of GE HealthCare Technologies by 49.9% during the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after buying an additional 1,711,963 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of GE HealthCare Technologies by 3.3% during the first quarter. Dimensional Fund Advisors LP now owns 4,943,579 shares of the company’s stock worth $398,975,000 after buying an additional 157,839 shares during the period. Canada Pension Plan Investment Board boosted its stake in shares of GE HealthCare Technologies by 15.2% during the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock worth $251,121,000 after buying an additional 409,636 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of GE HealthCare Technologies by 3.7% during the first quarter. Charles Schwab Investment Management Inc. now owns 3,069,114 shares of the company’s stock worth $247,708,000 after buying an additional 109,858 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Up 0.8%

NASDAQ GEHC opened at $76.10 on Wednesday. The stock has a market capitalization of $34.74 billion, a P/E ratio of 15.59, a P/E/G ratio of 2.88 and a beta of 1.13. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The firm has a 50-day moving average price of $74.60 and a 200 day moving average price of $72.16. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same period in the prior year, the company posted $1.00 earnings per share. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.87%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Tuesday, October 14th. Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, September 18th. Barclays assumed coverage on shares of GE HealthCare Technologies in a research note on Monday, October 13th. They set an “equal weight” rating and a $86.00 target price for the company. Citigroup downgraded shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $93.00 to $83.00 in a research note on Tuesday, October 7th. Finally, Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $85.20.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.